Home › Prostate Cancer › Oregon
Prostate Cancer clinical trials in Oregon
38 studies for Prostate Cancer are looking for participants at sites in Oregon.
Cities in Oregon
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
- Oregon Health And Science University, Portland
RecruitingPhase 1
Ages 18 and older · Men · Updated Sep 28, 2026 · NCT06095089Precision-Based Genomics in Prostate Cancer
- Oregon Health Sciences University, Portland
RecruitingObservational study
Ages 18 to 120 · Men · Updated Sep 28, 2026 · NCT04706663Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Saint Alphonsus Cancer Care Center-Ontario, Ontario
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- and 1 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT03866382A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread
- Providence Portland Medical Center, Portland
RecruitingPhase 1
Ages 18 and older · Men · Updated Sep 24, 2026 · NCT07543055Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- Oregon Urology Institute, Springfield
RecruitingPhase 2/3
Ages 18 to 100 · Men · Updated Sep 22, 2026 · NCT06780670A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- Oregon Oncology Specialists, Salem
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 22, 2026 · NCT07213674A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
- Research Site, Springfield
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 18, 2026 · NCT06952803Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
- VA Portland Health Care System, Portland, OR, Portland
RecruitingPhase 2
Ages 18 and older · Men · Updated Sep 17, 2026 · NCT04038502High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
- VA Portland Health Care System, Portland, OR, Portland
RecruitingPhase 2
Ages 18 and older · Men · Updated Sep 17, 2026 · NCT05011383A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- VA Portland Health Care System ( Site 0038), Portland
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 17, 2026 · NCT06925737The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Oregon Health & Science University (OHSU), Portland
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated Sep 15, 2026 · NCT04585750Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- Oregon Urology, Springfield
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 11, 2026 · NCT06056830Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Saint Charles Health System, Bend
- Clackamas Radiation Oncology Center, Clackamas
- Providence Portland Medical Center, Portland
- and 2 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 10, 2026 · NCT05946213Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence
- Oregon Health & Science University, Portland
RecruitingPhase 4
Ages 18 and older · Men · Updated Sep 8, 2026 · NCT07569926Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Saint Alphonsus Cancer Care Center-Baker City, Baker City
- Saint Charles Health System, Bend
- Clackamas Radiation Oncology Center, Clackamas
- and 8 more
RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 75 · All sexes · Updated Sep 2, 2026 · NCT05334069Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 2, 2026 · NCT07200830Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- Oregon Health and Science University, Portland
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT06632977MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy
- Oregon Health & Science University, Portland
Recruiting
Ages 18 and older · Men · Updated Sep 1, 2026 · NCT05710380A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
- Oregon Health & Science University, Portland
RecruitingPhase 2
Ages 18 and older · Men · Updated Aug 31, 2026 · NCT05726292Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
- Research Site, Portland
RecruitingPhase 1/2
Ages 18 to 99 · Men · Updated Aug 27, 2026 · NCT07590934AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- Research Site, Portland
RecruitingPhase 3
Ages 18 and older · Men · Updated Aug 26, 2026 · NCT07611110A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
- VA Portland Health Care System, Portland, OR, Portland
RecruitingPhase 2
Ages 18 and older · Men · Updated Aug 25, 2026 · NCT05593497Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Saint Charles Health System, Bend
- Clackamas Radiation Oncology Center, Clackamas
- Bay Area Hospital, Coos Bay
- and 5 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Aug 19, 2026 · NCT04423211FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Oregon Health and Science University, Portland
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT05919264Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Saint Charles Health System, Bend
- Clackamas Radiation Oncology Center, Clackamas
- Bay Area Hospital, Coos Bay
- and 8 more
RecruitingPhase 3
Ages 18 and older · Men · Updated Jul 14, 2026 · NCT06592924A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
- Oregon Health & Science University, Portland
RecruitingPhase 1/2
Ages 18 and older · Men · Updated Jun 25, 2026 · NCT06457919Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
- VA Portland Health Care System, Portland
RecruitingPhase 2
Ages 18 and older · Men · Updated Jun 15, 2026 · NCT05422911International Registry for Men With Advanced Prostate Cancer (IRONMAN)
- Oregon Health & Science University Hospital, Portland
RecruitingObservational study
Ages 21 and older · Men · Updated May 22, 2026 · NCT03151629Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
- OHSU Knight Cancer Institute, Portland
RecruitingObservational studyHealthy volunteers welcome
Ages 40 and older · Men · Updated May 15, 2026 · NCT04472338A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
- Research Site, Portland
RecruitingPhase 1
Ages 18 and older · Men · Updated May 12, 2026 · NCT06879041Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors, iLIVE
- OHSU Knight Cancer Institute, Portland
Recruiting
Ages 18 and older · All sexes · Updated May 8, 2026 · NCT06011499GET FIT Together: Testing a Socially Enhanced Exercise Program in Older Men With Prostate Cancer
- OHSU Knight Cancer Institute, Portland
Recruiting
Ages 65 and older · Men · Updated May 6, 2026 · NCT07504835Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
- Saint Alphonsus Medical Center-Baker City, Baker City
- Saint Charles Health System, Bend
- Clackamas Radiation Oncology Center, Clackamas
- and 9 more
RecruitingPhase 2
Ages 18 and older · Men · Updated Jan 29, 2026 · NCT05806515Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
- Saint Alphonsus Cancer Care Center-Baker City, Baker City
- Saint Alphonsus Cancer Care Center-Ontario, Ontario
RecruitingPhase 3
Ages 18 and older · Men · Updated Jan 22, 2026 · NCT06470243cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Oregon Health Sciences University, Portland
RecruitingObservational studyHealthy volunteers welcome
Ages 40 and older · All sexes · Updated Jan 20, 2026 · NCT05366881SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Portland
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774EMBRACE: Exercising Together
- OHSU Knight Cancer Institute, Portland
RecruitingPhase 2Healthy volunteers welcome
Ages 18 and older · All sexes · Updated May 29, 2025 · NCT06049355Neoadjuvant Pembrolizumab Plus Androgen Axis Blockade Prior to Prostatectomy for High Risk Localized Prostate Cancer
- VA Portland Healthcare System, Portland
RecruitingPhase 2
Ages 18 and older · Men · Updated Apr 20, 2022 · NCT03753243From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.